NIH: HPV test beats Pap for cancer assessment

Share this article:

The National Institutes of Health released the results of a study Friday that showed a negative Human Papillomavirus test result was more accurate than a negative Pap smear result when it comes to assessing future risk, meaning “women who test negative on the HPV test have an extremely low risk of developing cervical cancer.”

The NIH explains that whereas HPV tests seek out the DNA and RNA (smaller picture) of the virus that is associated with just about every type of cervical cancer, Pap smears identify abnormal cells (bigger picture) associated with cervical cancer.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.